Sven Almer

Karolinska Institutet

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Collaborators (6)

Jan Marsal

Elisabeth Almer Boström

Karolinska Institutet

Carl Eriksson

Adjunct Senior Lecturer

Örebro university

Philip Rosenstiel

Kiel University

Carl Mårten Lindqvist

Örebro university

Mauro D'Amato

Professor of Medical Gentics

LUM Jean Monnet University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sven Almer

Research Interests

Explore related searches

Contact this professor

Articles (20)

Collaborators (6)

Jan Marsal

Elisabeth Almer Boström

Carl Eriksson

Philip Rosenstiel

Carl Mårten Lindqvist

Mauro D'Amato

Make your next move.

Sven Almer

Research Interests

Explore related searches

Contact this professor

Articles (20)

Classification of Paediatric Celiac Disease Using RNA Sequencing and Real‐Time PCR of Duodenal Biomarkers

Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD).

Preclinical Protein Signatures of Crohn's Disease and Ulcerative Colitis: A Nested Case-Control Study Within Large Population-Based Cohorts.

Response to azathioprine treatment in autoimmune hepatitis is dependent on glutathione transferase genotypes

Salivary calprotectin and neutrophils in inflammatory bowel disease in relation to oral diseases.

Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes.

Early monitoring of ustekinumab concentration after induction is related to clinical remission in ulcerative colitis & Crohn`s disease - STOCUSTE study

Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.

Long-term real-world data of ustekinumab in ulcerative colitis: the Stockholm Ustekinumab Study (STOCUSTE)

Relation between Crohn's disease phenotype and response to ustekinumab in Stockholm - the STOCUSTE study

Differences in Whole-Blood Transcriptional Profiles in Inflammatory Bowel Disease Patients Responding to Vedolizumab Compared with Non-Responders

Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study

Downregulated Mucosal Autophagy, Alpha Kinase-1 and IL-17 Signaling Pathways in Active and Quiescent Ulcerative Colitis

Inverse and Concordant Mucosal Pathway Gene Expressions in Inflamed and Non-Inflamed Ulcerative Colitis Patients: Potential Relevance to Aetiology and Pathogenesis

Detailed Transcriptional Landscape of Peripheral Blood Points to Increased Neutrophil Activation in Treatment-Naive Inflammatory Bowel Disease

Whipple's disease: the great masquerader—a high level of suspicion is the key to diagnosis

Clinical effectiveness of golimumab in ulcerative colitis: a prospective multicentre study based on the Swedish IBD Quality Register, SWIBREG

Association Between Collagenous and Lymphocytic Colitis and Risk of Severe Coronavirus Disease 2019

Effect of vedolizumab therapy on whole blood transcriptional profiles in patients with Inflammatory Bowel Disease

Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective multicentre SVEAH study

Collaborators (6)

Jan Marsal

Elisabeth Almer Boström

Carl Eriksson

Philip Rosenstiel

Carl Mårten Lindqvist

Mauro D'Amato

Make your next move.